SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

Stephen V. Faraone, PhD

Speaker Affiliation
Stephen V. Faraone, PhD
Departments of Psychiatry and of Neuroscience and Physiology
SUNY Upstate Medical University
Syracuse, NY

: Late Onset and Atypical Forms of ADHD
Activity/Course #:
: Free
Release/Start Date:
: Apr 05 2017
Expiration Date:
: Apr 04 2020
: Psychiatry
Target Audience:
: Primary Care Providers
: ADHD Dissemination Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 1.0 AMA PRA Category I Credit(s)
Hardware/Software Requirements:
In this 50 minute presentation, Stephen V. Faraone, PhD presents atypical cases of ADHD which can confound diagnosis in the clinical setting. Clinical guidance is given in clarifying how to diagnose ADHD with late onset beyond the DSM-5 age of 12, as well as individuals with both low and high IQ who may also have ADHD.

Learning Objectives
After completing this activity, the reader should be better able to:

  1. Separate the symptoms of intellectual disability and low IQ from symptoms of ADHD in order to make an ADHD diagnosis.
  2. Identify significant impairments in high IQ that may lead to an ADHD diagnosis despite intelligence.
  3. Diagnose young adults with ADHD whose symptoms may have developed or become more severe at ages older than the DSM-5 criterion of age 12.

This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure is provided below.

Stephen V. Faraone, PhD, Speaker, has the following relationships to disclose: serves as a researcher for Shire, IronShore and Arbor. He is also consultant for Akili, VAYA, CogCubed, NeuroLife Sciences, Alcobra and IronShore. He has traveled to consult at meetings for Shire, Alcobra and IronShore. Dr. Faraone receives royalties from NHE Inhibitor Patent, Guliford Press and Oxford University Press and is an IronShore stockholder.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationships to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Jonathan Marx, Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, CCHCP, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
ADHD in Adults was originally supported by a generous grant from the Agency for Health Research and Quality (AHRQ).

Continued support was provided by an independent medical educational grant from Shire and an educational grant from Arbor Pharmaceuticals.